Category: Oncology/Hematology
Oncology/Hematology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Cancer Stem Cells
The 2025-2030 World Outlook for Cancer Stem Cells This study covers the world outlook for cancer stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Cancer Therapeutics
The 2025-2030 World Outlook for Cancer Therapeutics This study covers the world outlook for cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Radiation Oncology
The 2025-2030 World Outlook for Radiation Oncology This study covers the world outlook for radiation oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Cancer Immunotherapies
The 2025-2030 World Outlook for Cancer Immunotherapies This study covers the world outlook for cancer immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Interventional Oncology
The 2025-2030 World Outlook for Interventional Oncology This study covers the world outlook for interventional oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies
The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies This study covers the world outlook for breast cancer diagnostics and drug technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostic and Drugs
The 2025-2030 World Outlook for Breast Cancer Diagnostic and Drugs This study covers the world outlook for breast cancer diagnostic and drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Hemato Oncology Testing
The 2025-2030 World Outlook for Hemato Oncology Testing This study covers the world outlook for hemato oncology testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Hematology and Oncology Products
The 2025-2030 World Outlook for Hematology and Oncology Products This study covers the world outlook for hematology and oncology products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Urothelial Cancer Drugs
The 2025-2030 World Outlook for Urothelial Cancer Drugs This study covers the world outlook for urothelial cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs
The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs This study covers the world outlook for endocrine pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Endometrial Cancer Treatments
The 2025-2030 World Outlook for Endometrial Cancer Treatments This study covers the world outlook for endometrial cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Imaging Devices
The 2025-2030 World Outlook for Breast Cancer Imaging Devices This study covers the world outlook for breast cancer imaging devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Diagnostics
The 2025-2030 World Outlook for Ovarian Cancer Diagnostics This study covers the world outlook for ovarian cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Drugs
The 2025-2030 World Outlook for Ovarian Cancer Drugs This study covers the world outlook for ovarian cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Embolization in Interventional Oncology
The 2025-2030 World Outlook for Embolization in Interventional Oncology This study covers the world outlook for embolization in interventional oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Kidney Cancer-Treating Drugs
The 2025-2030 World Outlook for Kidney Cancer-Treating Drugs This study covers the world outlook for kidney cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Cancer Diagnostics
The 2025-2030 World Outlook for Cancer Diagnostics This study covers the world outlook for cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Transitional Cell Bladder Cancer Therapeutics
The 2025-2030 World Outlook for Transitional Cell Bladder Cancer Therapeutics This study covers the world outlook for transitional cell bladder cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Generic Oncology Drugs
The 2025-2030 World Outlook for Generic Oncology Drugs This study covers the world outlook for generic oncology drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Blockbuster Oncology Brands
The 2025-2030 World Outlook for Blockbuster Oncology Brands This study covers the world outlook for blockbuster oncology brands across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Melanoma Diagnostics and Therapeutics
The 2025-2030 World Outlook for Melanoma Diagnostics and Therapeutics This study covers the world outlook for melanoma diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Anaplastic Thyroid Cancer Drugs
The 2025-2030 World Outlook for Anaplastic Thyroid Cancer Drugs This study covers the world outlook for anaplastic thyroid cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Blood-Product Hematology Drugs
The 2025-2030 World Outlook for Blood-Product Hematology Drugs This study covers the world outlook for blood-product hematology drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings
The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings This study covers the world outlook for fecal occult blood tests for in-vitro colorectal cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent dem ... Read More
Research Assistance
